Brokerages Set Herbalife Ltd. (NYSE:HLF) Price Target at $10.50

Herbalife Ltd. (NYSE:HLFGet Free Report) has earned an average rating of “Reduce” from the five brokerages that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating and four have given a hold rating to the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $10.50.

A number of analysts recently weighed in on HLF shares. Mizuho lowered their price target on shares of Herbalife from $12.00 to $10.00 and set a “neutral” rating for the company in a report on Thursday, March 21st. DA Davidson reissued a “neutral” rating and issued a $9.50 price target on shares of Herbalife in a report on Thursday, May 2nd. StockNews.com lowered shares of Herbalife from a “buy” rating to a “hold” rating in a report on Friday, May 17th. Finally, Bank of America lowered their target price on shares of Herbalife from $10.00 to $8.00 and set an “underperform” rating for the company in a report on Thursday, March 21st.

View Our Latest Stock Report on Herbalife

Insiders Place Their Bets

In other Herbalife news, Director Donal L. Mulligan purchased 30,000 shares of the business’s stock in a transaction on Friday, May 3rd. The shares were purchased at an average cost of $9.65 per share, with a total value of $289,500.00. Following the transaction, the director now directly owns 60,000 shares of the company’s stock, valued at approximately $579,000. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, Director Donal L. Mulligan acquired 30,000 shares of the stock in a transaction dated Friday, May 3rd. The shares were bought at an average cost of $9.65 per share, for a total transaction of $289,500.00. Following the purchase, the director now directly owns 60,000 shares of the company’s stock, valued at $579,000. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Henry C. Wang acquired 2,778 shares of the stock in a transaction dated Tuesday, March 26th. The shares were purchased at an average price of $9.30 per share, for a total transaction of $25,835.40. Following the completion of the purchase, the executive vice president now directly owns 176,194 shares in the company, valued at $1,638,604.20. The disclosure for this purchase can be found here. Insiders have acquired 66,532 shares of company stock valued at $643,642 in the last three months. 0.94% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the company. Iridian Asset Management LLC CT raised its holdings in Herbalife by 49.1% in the 4th quarter. Iridian Asset Management LLC CT now owns 1,468,636 shares of the company’s stock valued at $22,411,000 after acquiring an additional 483,635 shares during the period. UBS Group AG raised its holdings in Herbalife by 5.6% in the 3rd quarter. UBS Group AG now owns 3,989,128 shares of the company’s stock valued at $55,808,000 after acquiring an additional 209,949 shares during the period. Vanguard Group Inc. raised its holdings in Herbalife by 0.4% in the 3rd quarter. Vanguard Group Inc. now owns 10,561,779 shares of the company’s stock valued at $147,759,000 after acquiring an additional 43,452 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in Herbalife by 9.2% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,742,507 shares of the company’s stock valued at $24,378,000 after acquiring an additional 147,003 shares during the period. Finally, Campbell & CO Investment Adviser LLC bought a new position in Herbalife in the 3rd quarter valued at about $381,000.

Herbalife Trading Up 0.4 %

NYSE:HLF opened at $11.28 on Monday. The stock has a market capitalization of $1.13 billion, a P/E ratio of 8.23 and a beta of 1.24. The firm has a 50 day moving average of $9.29 and a 200-day moving average of $11.24. Herbalife has a 1 year low of $6.68 and a 1 year high of $19.48.

Herbalife (NYSE:HLFGet Free Report) last issued its quarterly earnings results on Wednesday, May 1st. The company reported $0.49 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.12. The business had revenue of $1.30 billion during the quarter, compared to analyst estimates of $1.26 billion. Herbalife had a net margin of 2.70% and a negative return on equity of 19.97%. Herbalife’s revenue for the quarter was up 3.8% compared to the same quarter last year. During the same quarter last year, the business posted $0.54 earnings per share. As a group, analysts forecast that Herbalife will post 1.48 EPS for the current fiscal year.

Herbalife Company Profile

(Get Free Report

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.

See Also

Analyst Recommendations for Herbalife (NYSE:HLF)

Receive News & Ratings for Herbalife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife and related companies with MarketBeat.com's FREE daily email newsletter.